A-View
OtherPre-operative imaging of the thoracic aorta with A-View technique
Other names: The A-View®, Aortic-view®, Modified transoesophageal echocardiography, FDA: 070515
NCT Number: NCT01310608
Patients undergoing cardiac surgery frequently develop neurologic complications, ranging from subtle cognitive changes to evident confusion, delirium, and stroke. This continuum of complications is commonly caused by embolization in the brain due to manipulation of atherosclerotic parts of the aorta ascendens (AA) during surgery. Timely detection of AA atherosclerosis before surgery enables the surgeon to consider changes of the surgical plan, to reduce the risk of embolization and thus subsequent neurologic complications.
Various methods exist to visualize the AA to detect atherosclerosis. Epiaortic ultrasound scanning has become the gold standard, but is seldom used as it interferes often with surgical plan and can only be used after sternotomy. Transesophageal echocardiography (TEE) is a widely used imaging method permitting evaluation of the aorta preoperatively, but assessment of distal AA is hampered by interposition of air-filled trachea between esophagus and AA. The A-View® (Aortic-view) method, a modification of conventional TEE using a fluidfilled balloon, overcomes this limitation. The safety and diagnostic accuracy of the A-View® have successfully been shown in previous studies. The hypothesis of this study is that the use of A-View will reduce cerebral embolization secondary to a change of surgical technique.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pre-operative imaging of the thoracic aorta with A-View technique
Other names: The A-View®, Aortic-view®, Modified transoesophageal echocardiography, FDA: 070515
Time frame: 3 - 4 Days after intervention
Time frame: 3 - 4 Days after intervention
Time frame: 6 weeks postoperative
Time frame: 3 months postoperative
Time frame: Until hospital discharge
Time frame: 6 weeks and 1 year after the intervention
Time frame: peroperive
Time frame: Peroperative
Time frame: 6 weeks after intervention
Isala
Other
Effect of Preoperative Imaging of the Ascending Aorta With Modified Transoesophageal Echocardiography on New Dw-MRI Lesions After Cardiac Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07552948
Arterial Occlusive Diseases, Arteriosclerosis
Tomsk, Russia
View Trial DetailsNCT07262359
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT04010955
Acute Ischemic Stroke, Anticoagulant
Seoul, South Korea
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial Details